Translate
Cel-sci Corporation
About
1.43USD+0.13 +10.00%
Closed • Updated at 11:28 GMT+00:00Market Cap$12.09M
Volume1.12M
Beta2.36
RSI31.17
Cel-sci Corporation — investor relations, events, news, and company updates on 6ix.
Latest News
May 12 2026
CEL-SCI Corporation Announces Pricing of Public Offering
May 11 2026
CEL-SCI Enters Strategic Agreement with Amarox for the Registration, Commercialization, and Distribution of Multikine in Saudi Arabia
Feb 18 2026
CEL-SCI Reports Fiscal First Quarter 2026 Results
Dec 29 2025
CEL-SCI Reports Fiscal 2025 Results
Oct 20 2025
CEL-SCI Presentation at LD Micro "Main Event" Available on Tuesday, October 21, 2025
Recent Videos
CEL-SCI Stock Sale: My Take on the 8-K Filing
May 15, 2026
Top 3 Losers: $BIYA -26%, CVM, SMMT
May 01, 2026
#CVM #nasdaq CEL-SCI Corporation is a biotechnology firm focused on developing immunotherapies.
Apr 19, 2026
🚨 $CVM ALERT – FDA PIVOTAL TRIAL LOADING SUMMER 2026! 🔥🩺💥
Mar 03, 2026